PE20151608A1 - Formulacion que comprende un compuesto de benzotiazolona - Google Patents

Formulacion que comprende un compuesto de benzotiazolona

Info

Publication number
PE20151608A1
PE20151608A1 PE2015001827A PE2015001827A PE20151608A1 PE 20151608 A1 PE20151608 A1 PE 20151608A1 PE 2015001827 A PE2015001827 A PE 2015001827A PE 2015001827 A PE2015001827 A PE 2015001827A PE 20151608 A1 PE20151608 A1 PE 20151608A1
Authority
PE
Peru
Prior art keywords
formulation including
benzothiazolone compound
hydroxy
benzothiazolone
compound
Prior art date
Application number
PE2015001827A
Other languages
English (en)
Inventor
Miloud Achour
Robin Alec Fairhurts
Arnaud Grandeury
Shinji Hatakeyama
Magdalena Koziczak-Holbro
Nicola Tufilli
Thomas Ullrich
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20151608A1 publication Critical patent/PE20151608A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se refiere a una composicion farmaceutica en forma de dosificacion oral solida que comprende la sal de acetato de la (R)-7-(2-(1-(4-butoxi-fenil)-2-metil-propan-2-il-amino)-1-hidroxi-etil)-5-hidroxi-benzo-[d]-tiazol-2(3H)-ona
PE2015001827A 2013-02-28 2014-02-26 Formulacion que comprende un compuesto de benzotiazolona PE20151608A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361770584P 2013-02-28 2013-02-28

Publications (1)

Publication Number Publication Date
PE20151608A1 true PE20151608A1 (es) 2015-11-19

Family

ID=50238437

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015001827A PE20151608A1 (es) 2013-02-28 2014-02-26 Formulacion que comprende un compuesto de benzotiazolona

Country Status (31)

Country Link
US (1) US9623012B2 (es)
EP (1) EP2961391B1 (es)
JP (2) JP6230626B2 (es)
KR (1) KR20150120386A (es)
CN (1) CN104968337A (es)
AU (1) AU2014222362B2 (es)
BR (1) BR112015020059A2 (es)
CA (1) CA2897565A1 (es)
CL (1) CL2015001940A1 (es)
CY (1) CY1119202T1 (es)
DK (1) DK2961391T3 (es)
EA (1) EA026914B1 (es)
ES (1) ES2637802T3 (es)
HK (1) HK1212213A1 (es)
HR (1) HRP20171177T1 (es)
HU (1) HUE034353T2 (es)
IL (1) IL240495A0 (es)
LT (1) LT2961391T (es)
MA (1) MA38354B1 (es)
MX (1) MX2015011290A (es)
NZ (1) NZ709747A (es)
PE (1) PE20151608A1 (es)
PH (1) PH12015501701A1 (es)
PL (1) PL2961391T3 (es)
PT (1) PT2961391T (es)
SA (1) SA515360952B1 (es)
SG (1) SG11201505544RA (es)
SI (1) SI2961391T1 (es)
TN (1) TN2015000310A1 (es)
WO (1) WO2014132205A1 (es)
ZA (1) ZA201504863B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3192B1 (ar) 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
SG10201704377PA (en) * 2012-08-30 2017-06-29 Novartis Ag Salts of benzothiazolone compound as beta-2-adrenoceptor agonist
PE20151608A1 (es) * 2013-02-28 2015-11-19 Novartis Ag Formulacion que comprende un compuesto de benzotiazolona

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078163A2 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
PE20050130A1 (es) 2002-08-09 2005-03-29 Novartis Ag Compuestos organicos
WO2005110990A1 (de) 2004-05-13 2005-11-24 Boehringer Ingelheim International Gmbh Hydroxy-substituierte benzkondensierte heterozyklen als betaagonisten zur behandlung von atemwegserkrankungen
GB0426164D0 (en) * 2004-11-29 2004-12-29 Novartis Ag Organic compounds
DE102009003975A1 (de) * 2009-01-07 2010-07-08 Merck Patent Gmbh Benzothiazolonderivate
JO3192B1 (ar) * 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
PE20151608A1 (es) * 2013-02-28 2015-11-19 Novartis Ag Formulacion que comprende un compuesto de benzotiazolona

Also Published As

Publication number Publication date
US9623012B2 (en) 2017-04-18
SA515360952B1 (ar) 2016-07-10
MA38354A1 (fr) 2016-02-29
MA38354B1 (fr) 2016-09-30
EA026914B1 (ru) 2017-05-31
US20160000761A1 (en) 2016-01-07
CN104968337A (zh) 2015-10-07
CL2015001940A1 (es) 2015-10-30
JP6230626B2 (ja) 2017-11-15
SI2961391T1 (sl) 2017-08-31
SG11201505544RA (en) 2015-09-29
IL240495A0 (en) 2015-09-24
EP2961391A1 (en) 2016-01-06
AU2014222362B2 (en) 2016-07-21
PT2961391T (pt) 2017-08-29
CY1119202T1 (el) 2018-02-14
AU2014222362A1 (en) 2015-07-23
ES2637802T3 (es) 2017-10-17
EP2961391B1 (en) 2017-05-17
JP2016510020A (ja) 2016-04-04
HK1212213A1 (en) 2016-06-10
LT2961391T (lt) 2017-07-25
HUE034353T2 (en) 2018-02-28
KR20150120386A (ko) 2015-10-27
PH12015501701A1 (en) 2015-10-12
HRP20171177T1 (hr) 2017-10-06
MX2015011290A (es) 2015-12-03
NZ709747A (en) 2018-04-27
WO2014132205A1 (en) 2014-09-04
TN2015000310A1 (en) 2017-01-03
JP2018035186A (ja) 2018-03-08
BR112015020059A2 (pt) 2017-07-18
CA2897565A1 (en) 2014-09-04
EA201591577A1 (ru) 2015-12-30
ZA201504863B (en) 2016-06-29
DK2961391T3 (en) 2017-09-04
PL2961391T3 (pl) 2017-10-31

Similar Documents

Publication Publication Date Title
IL283032A (en) Preparations for oral administration of tofacitinib
IL264259A (en) Oral formulations of pyrrolidine derivatives
HK1257400A1 (zh) 用於治療疾病的唑來膦酸或相關化合物的經口施用組合物
IL244636B (en) Toothpaste for administering allergens to the oral mucosa
CO7141434A2 (es) Nueva forma de dosificación formulación de abediterol
EA201591259A1 (ru) Твёрдые формы производного хиназолина и их применение в качестве ингибитора braf
IL241367A0 (en) Pharmaceutical composition for oral dual use of tablets of sulfate salts and methods of using it
PE20151608A1 (es) Formulacion que comprende un compuesto de benzotiazolona
CO7111279A2 (es) Composiciones farmacéuticas orales estables de liberación inmediata que contienen prasugrel
BR112016008704A8 (pt) derivados de indol-urea glucopiranosil-substituídos, composições farmacêuticas, e seus usos
PE20151432A1 (es) Formulaciones de lorazepam de liberacion sostenida
PL395069A1 (pl) Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego
CL2015000066A1 (es) Composición para el cuidado oral que comprende particulas de una sal de metal; uso de la composicion para blanquear el esmalte de los dientes.
EP2979698A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
LT2988782T (lt) Dozavimo formos, skirtos peroraliniam veikliųjų medžiagų vartojimui
CU20150043A7 (es) Inhibidores de la tirosina-quinasa de bruton
ITMI20120350A1 (it) Forma di dosaggio per somministrazione orale di principi attivi

Legal Events

Date Code Title Description
FD Application declared void or lapsed